Arrowstreet Capital’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.43M Buy
310,383
+295,651
+2,007% +$4.22M ﹤0.01% 1215
2025
Q1
$155K Buy
+14,732
New +$155K ﹤0.01% 1751
2024
Q4
Sell
-25,677
Closed -$377K 1795
2024
Q3
$377K Buy
25,677
+2,563
+11% +$37.7K ﹤0.01% 1563
2024
Q2
$334K Buy
+23,114
New +$334K ﹤0.01% 1384
2023
Q2
Sell
-165,703
Closed -$1.56M 1287
2023
Q1
$1.56M Sell
165,703
-435,596
-72% -$4.1M ﹤0.01% 968
2022
Q4
$7.35M Buy
601,299
+260,171
+76% +$3.18M 0.01% 594
2022
Q3
$4.23M Buy
341,128
+133,969
+65% +$1.66M 0.01% 691
2022
Q2
$4.07M Buy
207,159
+128,439
+163% +$2.52M 0.01% 643
2022
Q1
$2.05M Buy
78,720
+35,535
+82% +$927K ﹤0.01% 803
2021
Q4
$1.23M Buy
+43,185
New +$1.23M ﹤0.01% 1119
2021
Q3
Sell
-5,980
Closed -$207K 1657
2021
Q2
$207K Buy
+5,980
New +$207K ﹤0.01% 1782
2021
Q1
Sell
-6,900
Closed -$212K 2309
2020
Q4
$212K Buy
+6,900
New +$212K ﹤0.01% 2180
2020
Q3
Sell
-70,300
Closed -$1.51M 2374
2020
Q2
$1.51M Sell
70,300
-1,093,025
-94% -$23.4M ﹤0.01% 1598
2020
Q1
$26M Sell
1,163,325
-192,893
-14% -$4.32M 0.07% 242
2019
Q4
$39.9M Buy
1,356,218
+561,568
+71% +$16.5M 0.09% 215
2019
Q3
$21.1M Buy
+794,650
New +$21.1M 0.05% 333
2019
Q2
Sell
-176,840
Closed -$5.67M 1467
2019
Q1
$5.67M Buy
+176,840
New +$5.67M 0.01% 745